{"id":"W1963599260","doi":"10.1016/j.clml.2013.05.012","title":"A Critical Review of Trials of First-Line BCR-ABL Inhibitor Treatment in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase","year":2013,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Nilotinib; Dasatinib; Imatinib; Medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; Tyrosine kinase; Internal medicine; Clinical trial; Oncology; Pharmacology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002581247,0.0008926913,0.004221435,0.002122336,0.000267619,0.00120112,0.00164365,0.001078602,0.00378601],"category_scores_gemma":[0.005790762,0.0004404104,0.002881592,0.002523683,0.0003989409,0.001083443,0.000587443,0.001313342,0.0004050979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001256473,"about_ca_system_score_gemma":0.002998557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002287054,"about_ca_topic_score_gemma":0.007208119,"domain_scores_codex":[0.9990495,0.0002632827,0.0003520744,0.000103428,0.000190622,0.00004111119],"domain_scores_gemma":[0.9969223,0.002071232,0.0005629717,0.00004204761,0.0003335144,0.00006794069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001036968,0.00006506103,0.0002946096,0.4838243,0.003493035,0.0001306851,0.00009754483,0.0002748115,0.0007526199,0.0008700106,0.02000813,0.4891523],"study_design_scores_gemma":[0.001780756,0.001377911,0.00460354,0.4038271,0.04673885,0.001378239,0.0002240177,0.0002200225,0.0007874158,0.001476928,0.5374982,0.0000871481],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000125106,0.9993048,0.00004556066,0.0001542385,0.00009702186,0.00002508752,0.00005333784,0.000002954579,0.0001918596],"genre_scores_gemma":[0.001320365,0.9977265,0.0002170888,0.0005001522,0.00006439017,0.00003076337,0.00005724288,0.000001477155,0.00008187451],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004221435,"threshold_uncertainty_score":0.01365113,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08339020883833671,"score_gpt":0.4046808406504899,"score_spread":0.3212906318121532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}